Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ShedRx vs Spry

ShedRx
Graded #3

Higher grade

vs+30.200000000000003
Spry
Graded #409

Lower grade

The verdict

ShedRx takes it — 87/100 to 56.8/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueShedRx +30
84
54
Dose & formulationShedRx +32
96
64
Clinical oversightShedRx +29
84
55
Labs & monitoringShedRx +32
84
52
FulfillmentShedRx +27
88
61
Contract termsShedRx +30
85
55
ShedRx · left barSpry · right bar

The numbers

MetricShedRxSpry
WeighScore87/10056.8/100
GradeB+C
Scorecard rank#3#409
Semaglutide$199/mo$199/mo (starting dose, compounded)
Tirzepatide$299/mo$299/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
ShedRx

Graded #3 · B+

Strengths

  • Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
  • Brand Zepbound and Wegovy available beside the compounded line
  • Health coaching included with membership, plus a published 120-day weight-loss guarantee

Where it loses points

  • The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard